izvor podataka: crosbi
!
Regdanvimab improves disease mortality and morbidity in patients with COVID-19: Too optimistic and too early to say? (CROSBI ID 322408)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Marcec, Robert ; Dodig, Vinko Michael ; Likic, Robert
Regdanvimab improves disease mortality and morbidity in patients with COVID-19: Too optimistic and too early to say? // The Journal of infection, 86 (2023), 1; 66-117. doi: 10.1016/j.jinf.2022.10.030
Podaci o odgovornosti
Marcec, Robert ; Dodig, Vinko Michael ; Likic, Robert
engleski
Regdanvimab improves disease mortality and morbidity in patients with COVID-19: Too optimistic and too early to say?
Utjecaj regdanvimaba na morbiditet i mortalitet pacijenata s COVID-19.
Regdanvimab ; mortality ; morbidity ; COVID-19 ;
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Povezane osobe
Povezane ustanove
Kliničke medicinske znanosti
Poveznice
Indeksiranost
